DiaMester

The DiaMester project is a collaboration between the HIT group at UiT The Arctic University of Norway, University of Oslo, Oslo University Hospital, ABEL Technologies AS, and the Norwegian Diabetes Association. The aim of the study is to develop a comprehensive e-health program to prevent, enhance self-management of, and potentially reverse type 2 diabetes in the population. End-users and their needs and preferences for an e-health program will be included throughout the project period. 

Several other researchers are involved. Those mentioned here are those involved from the HIT research group.

Novo Nordisk Norway AS (2021)